Previous studies demonstrated that the serum levels of CK-18-M30, FGF-21, IL-1Ra, PEDF and OPG exhibited significant differences in patients with NAFLD [40–43, 26]. This evidence concerns the gene TNFRSF11B and metabolic dysfunction-associated steatotic liver disease.